Temporal trends in cardiac arrest and cancer-related mortality among adults in the United States, 1999-2023 [0.03%]
1999至2023年美国成人心脏骤停和癌症相关死亡率的时空变化趋势
Reja Ahmad,Muhammad Salik Uddin,Urooj Amjad et al.
Reja Ahmad et al.
Cardiotoxicity prevention trials in the era of contemporary cancer therapies: a systematic review [0.03%]
当代癌症治疗时代的心脏毒性预防试验：系统性综述
Malak Munir,Ahmed Sayed,Sanam Ghazi et al.
Malak Munir et al.
Grace M Ferri,Manuel Urina-Jassir,Alexander V Stanisic et al.
Grace M Ferri et al.
Fluoropyrimidines, including 5-fluorouracil (5-FU), used in the treatment of patients with gastrointestinal malignancies, are associated with cardiotoxicity. Although the mechanism of this cardiotoxicity remains unknown, rat models treated ...
Outcomes associated with left atrial appendage occlusion in patients with cancer-associated atrial fibrillation: a real-world propensity-matched analysis [0.03%]
左心耳闭塞在癌性房颤患者中的结局：真实世界的倾向匹配分析
Rochell Issa,Tess Calcagno,Ryan Issa et al.
Rochell Issa et al.
Temporal trends, cardiovascular complications, and outcomes in patients receiving CAR T-cell therapy: a 6-year nationwide analysis [0.03%]
CAR-T细胞治疗患者的时效变化、心血管并发症和预后：一项为期六年的全国性分析研究
Karnav Modi,Himil Mahadevia,Raj Shah et al.
Karnav Modi et al.
Improvement of cardiac function by Ivabradine in a doxorubicin-induced cardiomyopathy murine model is associated with a normal renal angiotensin II type I receptor expression but not with a reduction in fibrosis [0.03%]
伊伐布雷定通过正常化肾脏血管紧张素Ⅱ受体AT1的表达改善阿霉素致小鼠心肌病模型的心功能但不减少纤维化
Gergana O Drumeva,Anne-Flore Plane,Daniil R Petrenyov et al.
Gergana O Drumeva et al.
Intrapericardial corticosteroid therapy for recurrent malignant pericardial effusion: a case series [0.03%]
胸膜内皮质类固醇治疗恶性心包积液复发：病例系列分析
Nuri Lee,Yoojin Kim,Hyukjin Park
Nuri Lee
Arterial stiffness in long-term breast cancer survivors: a propensity score-matched analysis in primary prevention [0.03%]
乳腺癌幸存者长期动脉僵硬度变化：一项初级预防倾向得分匹配分析研究
Renzo Melchiori,Miguel Rizzo,Noelia Brenzoni et al.
Renzo Melchiori et al.
Cardiotoxicity risk in metastatic castration-resistant prostate cancer: enzalutamide versus abiraterone [0.03%]
转移性去势抵抗性前列腺癌患者的心脏毒性风险：恩杂鲁胺与阿比特龙的比较
Alan H Bryce,David Nimke,Christopher Young et al.
Alan H Bryce et al.
Paediatric cardio-oncology: strengths and challenges in developing a collaborative care pathway between oncologists and cardiologists. the Italian experience [0.03%]
儿科心肿瘤学：意大利在肿瘤学家和心脏病学家之间建立协作护理路径方面的优势与挑战的经验
Alice Pozza,Elena Bennati,Nicoletta Bertorello et al.
Alice Pozza et al.